Latest News for ORIS
Company Receives Confirmation from Nasdaq that Minimum Bid Price Deficiency Has Been Resolved NINGDE, China, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Oriental Rise Holdings Limited (“Oriental Rise” or the “Company”) (NASDAQ: ORIS), an integrated tea supplier in mainland China, today announced that it has received written notification from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained…
Proposed Transaction Expected to Expand Ready-to-Drink Product Portfolio, Enhance White Tea Value Chain, and Broaden Health-Oriented Consumption Scenarios
Stock futures down, ORIS to acquire controlling stake in tea company, VNDA gets FDA approval, ELLO posts strong earnings.
Oriental Rise Holdings shares surged after a strategic acquisition announcement but remain near 52-week lows amid long-term weakness.
Proposed Transaction Expected to Enhance Upstream Supply Control, Improve Product Mix, and Further Advance Vertical Integration Strategy
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for ORIS.
Senate Trading
No Senate trades found for ORIS.
U.S. House Trading
No House trades found for ORIS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.